A total of 256 consecutive patients attending our out-patient clinic in Islamabad, Pakistan, with complaints of pain in or around the joints were evaluated for use of corticosteroids prescribed by medical practitioners they had seen earlier. The appropriateness of such prescriptions and their consequent effects were assessed. Of the 256 patients, 110 (i.e. 42.5%) were identified as steroid users; some of them were suffering from conditions known to be unresponsive to this form of therapy. One hundred and one of the 256 patients had rheumatoid arthritis and 67% of these had been using steroids, mostly in an irrational manner. The general practitioners and consultants (all non-rheumatologists) were responsible for the majority of steroid prescriptions. Steroid side-effects were observed in 42/110 (38.2%) cases. This prevalent practice in Pakistan is a reflection of the state of affairs in developing countries, and indicates a need for improvement and better regulation of health care in such countries.
C were introduced for the treatment of rheumatoid arthritis by Philip Hench in the late 1940s [1, 2] . The initial enthusiasm about their apparent success was soon tempered by the realization that there was a heavy price to pay for their continued use, in terms of their side-effects [3, 4] . Standard rheumatology texts today advocate their use in Q5% of cases of rheumatoid arthritis (RA) [5] . In clinical practice, however, they tend to be used in a greater percentage [6, 7] , mainly because of the perceived need in the individual patient and the growing impression that low-dose steroid therapy is associated with far less risk of side-effects than initially thought [8, 9] . Irrational use, even in low dosages, can still cause unacceptable side-effects and this is commonly observed in countries with loosely audited health care systems, e.g. the developing countries [10] . Pakistan is a representative Third World nation and in order to document the pattern, extent and consequences of steroid use for arthritis in this part of the world, this study was undertaken at our institute in Islamabad. METHODS A total of 256 consecutive patients attending our clinic with pain in and around the joints were studied. All patients aged over 13 yr were eligible for entry into this survey. The survey questionnaire (see the Appendix) was designed to assess the duration of symptoms, type of medical care sought earlier, use of steroids and the pertinence of such a prescription, and the recognizable side-effects of steroid therapy.
Disease diagnosis was made by the consultant rheumatologist (AF). Detailed interviews were carried out with the help of the survey questionnaire. Samples of various types of steroid tablets were shown to the patients to serve as an aide-me´moire to help in identifying their past or present use. Whereas it was possible, in most instances, to ascertain usage (or otherwise) of steroids if the patient had only sought alopathic care earlier, it was not so clear whether traditional healers had been involved as well because of their practice of handing out medicines in powdered rather than tablet form. Strong suspicion of use was aroused, of course, if the patient presented with a Cushingoid appearance or had dermal atrophy suggestive of chronic steroid ingestion.
The questionnaire used as our survey instrument was completely devised by us and has not been validated in any earlier survey. We found it useful and easy to apply without leaving too many ambiguities.
RESULTS
Disease categorization of the survey population and the numbers of those who were prescribed steroids are shown in Table I . This table accounts for definite or probable use of steroids as assessed by us. The category-wise sources of prescription are shown in Table II ; this may underestimate the contribution of traditional healers for the reasons mentioned above.
The overwhelming majority of prescriptions (78/ 110 = 71.7%) were for oral use of steroids. A total of 13.8% (16/110) of patients had been given injectable steroids. These were mostly i.m. and the rest intra-articular; none were i.v. An equal number of patients, i.e. 13.8%, were given a combination of oral and injectable steroids.
Patients in Pakistan usually carry their medical records (patchy as they are) with them. Scrutiny of these revealed that a specific diagnosis was available at the time of the initial steroid prescription in only 23.6% (26/110) of cases; 38.2% (42/110) definitely did not have a proper diagnosis and it was difficult to establish this fact in another 38.2%.
Laboratory and radiological work-up to establish a working diagnosis before embarking upon specific Specific attention was focused on the appropriateness of the use of steroids for patients suffering from RA. They had comprised 101/256 of our study population and 67% of them had been given steroids in a dosage pattern as indicated earlier. We found that nearly all these patients had had the drug prescribed before the use of disease-modifying anti-rheumatic drugs (DMARDs) was considered. Even the injectable forms of steroids were used as a quick-action substitute for oral therapy rather than measure up to the generally accepted bolus dosages [11] [12] [13] which may have been taken as remission-expediting therapy if DMARDs were also to be prescribed. A total of 15/67 (22.3%) were given a prescription of steroids plus a non-steroidal anti-inflammatory drug (NSAID) at their first visit to the medical practitioner. Three out of 67 (4.5%) were given steroids even before the use of an NSAID was considered and 42/67 (62.7%) were given steroids if the NSAID was considered ineffective in the first instance. Only nine of this group of 67 patients with RA went on to be prescribed DMARDs (and those too only by consultants) at a later stage.
Of the 110 patients identified as having been prescribed steroids, we assessed that 38.2% (42/110) exhibited one or more side-effects of this treatment (Table IV) . These included 22/26 of those who had been on continuous therapy (10-20 mg/day), 15/21 of the category who were on intermittent therapy and 5/7 of those in whom we could not ascertain the dosage and pattern. These side-effects were seen at all the dosage patterns recorded (especially if the use was continuous in nature). Their frequency rose with the amount ingested. therapy was missing in 48.6% (54/110) of the cases. Nearly a third (34/110 = 31.5%) did have some documentation indicating attempted work-up and we could not be sure of such past efforts in the remaining 20% (22/110) of steroid takers. It was not possible for us to establish the exact clinical condition of the patient at the time of the initial steroid prescription because of the inadequate medical records.
Most (60/110) of the steroid prescriptions were for short-term (1-3 weeks) use only, but a significant number (26/110) were on continuous steroid therapy. One-fifth of the patients (21/110) were using steroids on an intermittent basis since their first prescription. The majority of the prescriptions were for dosages ranging from 5 to 20 mg of prednisolone/day (Table III) . The pattern of use in three patients who had only been to traditional healers earlier could not be determined.
Quite alarmingly, we found that nearly a third of patients with osteoarthritis of the knees were given steroid prescriptions in the past; 22/91 of these had been given oral steroids (range 5-20 mg) and the remainder (8/91) had been given intra-articular injections. It appeared that these injections were given at times of increased mechanical pain in the knees rather than at times of acute synovitis complicating the pre-existing osteoarthritis. The total no. of patients prescribed steroids was 110.
The above-mentioned side-effects were seen in a total of 42 patients, either alone or in varying combinations. 
DISCUSSION
It is clear from our results that the use of steroid therapy for arthritis and related disorders is much more widespread in Pakistan as compared to the documented practice in the West. What is most alarming is the observation that in a number of instances (e.g. one-third of OA cases) the local practitioners seemed unable to differentiate between steroid-responsive and steroid-unresponsive conditions.
The issue of steroid use for RA was dominated by emotional discussions in the early days because of the observed adverse reactions (usually with dosages q20 mg/day or their equivalent) [3, 4] . This led to a generalized reduction in the number of steroid prescriptions. Their use became restricted to those with advanced RA or suffering from systemic complications of this disease. With time, experience with their cautious use has grown and the relative safety of using corticosteroids in low dosages for RA emphasized [14] . A recent study even advocates the use of low-dose (7.5 mg/day) prednisolone therapy as a means of modifying disease progression in RA [15] . Today, the use of steroid therapy for RA is accepted universally by rheumatologists as part of the overall disease management programme, which usually includes DMARDs as well. The non-rheumatologists, even in Western countries, often resort to short-term oral steroid use when confronted with an acute flare-up or increased joint pain in a patient with RA. This practice is not considered as safe as bolus i.m. or i.v. use because of the relatively greater number of adverse effects. If given at an early stage of arthritis of unknown cause, this may also serve to obscure the true diagnosis for a considerable time period. In countries where such drugs can be bought over the counter, the patients may be enticed to repeat the steroid prescription themselves and thus start a vicious cycle resulting in undue complications.
The fact that 54.5% of the steroid prescriptions were for a short duration (1-3 weeks) indicates a circumspect approach by the Pakistani doctors. It probably reflects a balance between the historical stigma of known adverse effects of steroids and the perceived need to provide quick relief to patients who are generally too poor to afford the expenses of diagnostic tests and also not educated enough to appreciate the benefits of long-term management programmes. However, the observation that 38.2% of patients on steroid therapy developed side-effects indicates that these were used in an irrational manner and should serve as a regretful warning against the profligate use of steroids. Iatrogenic Cushing's syndrome was seen in 29% of the steroid users and getting such patients back to some sort of normalcy remains one of our greatest therapeutic challenges. Studies advocating the use of steroids in low dosages, including the one by Kirwan [15] , acknowledge that adverse effects can be seen with such regimens if patients are not properly selected. Our study further proves this point.
The sources of these (mostly irrational) prescriptions were the general practitioners and consultants. Perhaps this reflects the unrestrained behaviour in an environment which is devoid of checks and balances, and free of the fear of litigation. The consequent poor results are a strong reason for the erosion of the public's confidence in our profession. Our services tend to be equated with the unscientific medicine practised by the traditional healers and should be a cause for concern for all doctors working in countries with a similar working environment.
The lack of rheumatology training and facilities in Pakistan has been documented earlier [16] . The newly formed Pakistan Society for Rheumatology proposes to create better awareness of the magnitude of problems and their solutions through education of their fellow physicians. Seminars and workshops are being arranged in different cities, and the policy makers are being gradually convinced of the need to establish more rheumatology centres in the country.
